Search Results - "Weidner, Ruth Ann"

Refine Results
  1. 1

    The Impact on Family of Pediatric Chronic Respiratory Failure in the Home by Graham, Robert J., MD, Rodday, Angie Mae, PhD, Weidner, Ruth Ann, MBA, MRP, Parsons, Susan K., MD, MRP

    Published in The Journal of pediatrics (01-08-2016)
    “…Objective To assess the family impact of managing severe, chronic respiratory failure (CRF) at home. Better understanding will inform parental counseling and…”
    Get full text
    Journal Article
  2. 2

    Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis by Esham, Kimberly S., Rodday, Angie Mae, Smith, Hedy P., Noubary, Farzad, Weidner, Ruth Ann, Buchsbaum, Rachel J., Parsons, Susan K.

    Published in Blood advances (14-01-2020)
    “…Sickle cell disease (SCD) is characterized by painful vaso-occlusive crises (VOCs). Self-reported pain intensity is often assessed with the Numeric Rating…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Leveraging pediatric PROMIS item banks to assess physical functioning in children at risk for severe functional loss by Rodday, Angie Mae, Graham, Robert J., Weidner, Ruth Ann, Rothrock, Nan E., Dewalt, Darren A., Parsons, Susan K.

    Published in Journal of patient-reported outcomes (01-01-2017)
    “…Background Pediatric neuromuscular illnesses often result in decreased health-related quality of life (HRQL), notably in physical functioning. Generic HRQL…”
    Get full text
    Journal Article
  5. 5

    Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors by Kumar, Anita J, Murphy-Banks, Rachel, Weidner, Ruth Ann, Parsons, Susan K

    Published in Blood (13-11-2019)
    “…Introduction The treatment landscape of Hodgkin Lymphoma (HL) has undergone a revolution in recent years, providing multiple options for providers and patients…”
    Get full text
    Journal Article
  6. 6

    Quantifying Social Disadvantage for Patients with Sickle Cell Disease: Implications for Quality of Care by Savidge, Nicole, Parsons, Susan K, Mao, Daqin, Weidner, Ruth Ann, Esham, Kimberly S, Rodday, Angie Mae

    Published in Blood (29-11-2018)
    “…Background: Socioeconomic disadvantage negatively affects healthcare utilization and disease outcomes. The Area Deprivation Index (ADI) is a well-established…”
    Get full text
    Journal Article
  7. 7

    Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis by Esham, Kimberly S, Rodday, Angie Mae, Savidge, Nicole, Mao, Daqin, Weidner, Ruth Ann, Parsons, Susan K

    Published in Blood (29-11-2018)
    “…Background: While there is no uniform definition of sickle cell disease (SCD) severity, vaso-occlusive crises (VOC) are the leading cause of emergency…”
    Get full text
    Journal Article
  8. 8

    Pilot study to assess a pharmacist- and medication navigator-led intervention of oral anticancer medication (OAM) adherence by Lin, Mingqian, Hackenyos, Douglas W., Parsons, Susan K., Rodday, Angie Mae, Murphy-Banks, Rachel, Weidner, Ruth Ann, Savidge, Nicole

    Published in Journal of clinical oncology (20-09-2019)
    “…Abstract only 58 Background: While advances in OAM make treatment more convenient for patients, OAM must be taken and handled correctly. Studies show gaps in…”
    Get full text
    Journal Article
  9. 9

    Pediatric Specialty Care Model for Management of Chronic Respiratory Failure: Cost and Savings Implications and Misalignment With Payment Models by Graham, Robert J, McManus, Michael L, Rodday, Angie Mae, Weidner, Ruth Ann, Parsons, Susan K

    Published in Pediatric critical care medicine (01-05-2018)
    “…To describe program design, costs, and savings implications of a critical care-based care coordination model for medically complex children with chronic…”
    Get full text
    Journal Article
  10. 10

    Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making and Late Effects by Kumar, Anita J., Murphy-Banks, Rachel, Weidner, Ruth Ann, Parsons, Susan K.

    Published in Clinical lymphoma, myeloma and leukemia (01-01-2022)
    “…Hodgkin Lymphoma (HL) survivors are at risk of treatment-related late effects (LEs). With these potential risks and increasing numbers of treatment options for…”
    Get full text
    Journal Article
  11. 11

    Contemporary use of inpatient antineoplastic (IP) treatment (Rx): Who is getting care and why? by Hachem, Hilal, Levitz, David, Dima, Danai, Dower, Joshua R., Fresco, Rabiah B., Weidner, Ruth Ann, Buchsbaum, Rachel J., Erban, John Kalil, Parsons, Susan K.

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e18015 Background: The steady trend towards outpatient antineoplastic medication delivery has been spurred by improvements in supportive care,…”
    Get full text
    Journal Article
  12. 12

    Assessment of Health-Related Quality of Life in Adults Hospitalized with Sickle Cell Disease Vaso-Occlusive Crisis by Esham, Kimberly S, Rodday, Angie Mae, Weidner, Ruth Ann, Buchsbaum, Rachel J., Smith, Hedy P, Parsons, Susan K

    Published in Blood (08-12-2017)
    “…Background: Sickle cell disease (SCD) is a chronic condition characterized by painful vaso-occlusive (VOC) episodes which lead to poor health-related quality…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Patients’ understanding and adherence to oral anti-cancer medication (OAM): Results of an institutional pilot study by Rodday, Angie Mae, Hackenyos, Douglas W, Masood, Raisa, Savidge, Nicole, Lin, Mingqian, Mao, Daqin, Wang, Feng Qing, Murphy-Banks, Rachel, Weidner, Ruth Ann, Buchsbaum, Rachel J., Erban, John Kalil, Parsons, Susan K.

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e18280 Background: Advancements in biopharmaceuticals have led to increasing availability and use of OAM. While oral medications allow patients…”
    Get full text
    Journal Article
  15. 15

    Health-Related Quality of Life (HRQL) Among Hospitalized Adults with Sickle Cell Disease (SCD): Incorporating Patient-Reported Outcome (PRO) Measures in Clinical Care by Esham, Kimberly S, Rodday, Angie Mae, Weidner, Ruth Ann, Buchsbaum, Rachel J., Smith, Hedy P, Parsons, Susan K

    Published in Blood (02-12-2016)
    “…Background: SCD is a chronic disease characterized by painful vaso-occlusive (VOC) episodes and hemolysis which lead to poor HRQL and premature mortality. As…”
    Get full text
    Journal Article
  16. 16

    Assessment of patients’ understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study by Rodday, Angie Mae, Hackenyos, Douglas, Masood, Raisa, Savidge, Nicole, Lin, Mingqian, Weidner, Ruth Ann, Parsons, Susan K

    Published in Journal of oncology pharmacy practice (01-10-2021)
    “…Background Although oral anticancer medications (OAM) provide opportunity for treatment at home, challenges include prescription filling, monitoring side…”
    Get full text
    Journal Article
  17. 17

    Opioid Utilization in Adults Hospitalized with Sickle Cell Pain Crises: An Understudied Population by Rodday, Angie Mae, Esham, Kimberly S, Savidge, Nicole S, Mao, Daqin, Weidner, Ruth Ann, Parsons, Susan K

    Published in Blood (29-11-2018)
    “…Background: Vaso-occlusive crises (VOC), also known as painful crises, are the hallmark of sickle cell disease (SCD) and adults hospitalized with VOC are among…”
    Get full text
    Journal Article
  18. 18

    Enhancing patients’ understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention by Lin, Mingqian, Hackenyos, Douglas, Savidge, Nicole, Weidner, Ruth Ann, Murphy-Banks, Rachel, Fleckner, Tara, Parsons, Susan K, Rodday, Angie Mae

    Published in Journal of oncology pharmacy practice (01-08-2021)
    “…Background Oral anticancer medications (OAM) make administration more convenient for patients, but shifts the responsibility of care from clinical providers to…”
    Get full text
    Journal Article
  19. 19

    Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer by Dong, Jinghui, Esham, Kimberly S., Boehm, Lauren, Karim, Sabrina A., Lin, Mingqian, Mao, Daqin, Wang, Fengqing, Fein, Daniel, Wang, Hanyin, Studenmund, Christine, Weidner, Ruth Ann, Noubary, Farzad, Freund, Karen M., Erban, John K., Parsons, Susan K.

    Published in Clinical breast cancer (01-02-2020)
    “…Evidence-based timeliness benchmarks have been established to assess quality of breast cancer care, as delays in treatment are associated with poor clinical…”
    Get full text
    Journal Article
  20. 20